{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreih3i5lcfjxt4gpiddf2wtbizcedsjvjz5zavjkl3vuhjxpy554r6e",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mk7wpaxewza2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibteaobco42pakzgzfgz7h5rexiandvuz36zqwdlkegq3ekaxgv4e"
    },
    "mimeType": "image/jpeg",
    "size": 93814
  },
  "path": "/2026/04/23/biotech-news-sanofi-research-priorities-in-flux-with-new-ceo/?utm_campaign=rss",
  "publishedAt": "2026-04-23T16:14:02.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "drug development",
    "Drug prices",
    "research"
  ],
  "textContent": "A gene therapy for deafness, all eyes on Erasca, and other biotech news from The Readout",
  "title": "STAT+: Sanofi research priorities in flux as new CEO logs in",
  "updatedAt": "2026-04-23T16:14:07.000Z"
}